Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway*

Cyclosporin A (CsA) is an immunosuppressant that inhibits protein phosphatase 2B (PP2B/calcineurin) and is associated with hyperlipidemia, decreased cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1), and increased risk of atherosclerosis. Apolipoprotein E (apoE) is an important regulator of lipid metabolism and atherosclerosis, the secretion of which from human macrophages is regulated by the serine/threonine protein kinase A (PKA) and intracellular calcium (Ca2+) (Kockx, M., Guo, D. L., Huby, T., Lesnik, P., Kay, J., Sabaretnam, T., Jary, E., Hill, M., Gaus, K., Chapman, J., Stow, J. L., Jessup, W., and Kritharides, L. (2007) Circ. Res. 101, 607–616). As PP2B is Ca2+-dependent and has been linked to PKA-dependent processes, we investigated whether CsA modulated apoE secretion. CsA dose- and time-dependently inhibited secretion of apoE from primary human macrophages and from Chinese hamster ovary cells stably transfected with human apoE and increased cellular apoE levels without affecting apoE mRNA. [35S]Met kinetic modeling studies showed that CsA inhibited both secretion and degradation of apoE, increasing the half-life of cellular apoE 2-fold. CsA also inhibited secretion from primary human Tangier disease macrophages and from mouse macrophages deficient in ABCA1, indicating that the effect is independent of the known inhibition of ABCA1 by CsA. The role of PP2B in mediating apoE secretion was confirmed using additional peptide and chemical inhibitors of PP2B. Importantly, kinetic modeling, live-cell imaging, and confocal microscopy all indicated that CsA inhibited apoE secretion by mechanisms quite distinct from those of PKA inhibition, most likely inducing accumulation of apoE in the endoplasmic reticulum compartment. Taken together, these results establish a novel mechanism for the pro-atherosclerotic effects of CsA, and establish for the first time a role for PP2B in regulating the intracellular transport and secretion of apoE.

[1]  K. Wasan,et al.  Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma. , 2008, International journal of pharmaceutics.

[2]  L. Kritharides,et al.  Regulation of endogenous apolipoprotein E secretion by macrophages. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[3]  L. Rohrer,et al.  Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI , 2008, Journal of Molecular Medicine.

[4]  I. Gelissen,et al.  Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1 , 2008, Circulation research.

[5]  K. Gaus,et al.  Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A– and Calcium-Dependent Pathway Along the Microtubule Network , 2007, Circulation research.

[6]  Vadim Zinchuk,et al.  Quantitative Colocalization Analysis of Multicolor Confocal Immunofluorescence Microscopy Images: Pushing Pixels to Explore Biological Phenomena , 2007, Acta histochemica et cytochemica.

[7]  M. Linton,et al.  A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Vaughan,et al.  ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease , 2006, Circulation research.

[9]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Sacks,et al.  Apolipoprotein-mediated pathways of lipid antigen presentation , 2005, Nature.

[11]  Dipak P. Ramji,et al.  The key role of apolipoprotein E in atherosclerosis , 2005, Journal of Molecular Medicine.

[12]  Jonathan D. Smith,et al.  Cyclosporin A Traps ABCA1 at the Plasma Membrane and Inhibits ABCA1-Mediated Lipid Efflux to Apolipoprotein A-I , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Z. Huang,et al.  Oleic Acid Modulates the Post-translational Glycosylation of Macrophage ApoE to Increase Its Secretion* , 2004, Journal of Biological Chemistry.

[14]  R. Dean,et al.  Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux* , 2004, Journal of Biological Chemistry.

[15]  Sheng-tian Li,et al.  Inhibition of excitatory neuronal cell death by cell‐permeable calcineurin autoinhibitory peptide , 2003, Journal of neurochemistry.

[16]  L. Miller Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  R. Traber,et al.  Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. , 2002, Journal of medicinal chemistry.

[18]  R. S. Kiss,et al.  Trypsin-sensitive and Lipid-containing Sites of the Macrophage Extracellular Matrix Bind Apolipoprotein A-I and Participate in ABCA1-dependent Cholesterol Efflux* , 2002, The Journal of Biological Chemistry.

[19]  D. Gu,et al.  Regulation of Macrophage ApoE Expression and Processing by Extracellular Matrix* , 2002, The Journal of Biological Chemistry.

[20]  R. Dean,et al.  A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1. , 2001, Biochemistry.

[21]  A. von Eckardstein,et al.  ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte‐derived macrophages , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  N. Vaziri,et al.  Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. , 2000, The Journal of pharmacology and experimental therapeutics.

[23]  T. Mazzone,et al.  Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. , 2000, Biochemistry.

[24]  T. Mazzone,et al.  Transport and Processing of Endogenously Synthesized ApoE on the Macrophage Cell Surface* , 2000, The Journal of Biological Chemistry.

[25]  A. Monks,et al.  Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. , 1999, Biochemical pharmacology.

[26]  T. Mazzone,et al.  Degradation of Macrophage ApoE in a Nonlysosomal Compartment , 1997, The Journal of Biological Chemistry.

[27]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[28]  C. Florén,et al.  Cyclosporine inhibits catabolism of low‐density lipoproteins in HepG2 cells by about 25% , 1996, Hepatology.

[29]  S. Snyder,et al.  Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux , 1995, Cell.

[30]  L. Dory,et al.  Lysosomal degradation and sorting of apolipoprotein E in macrophages. , 1995, Journal of lipid research.

[31]  S. Fazio,et al.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.

[32]  R. Dean,et al.  Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[33]  R. Mahley,et al.  Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. , 1994, The Journal of biological chemistry.

[34]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[35]  F. Kuipers,et al.  Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. , 1991, The Biochemical journal.

[36]  J. Taylor,et al.  Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.

[37]  V. Zannis,et al.  Intracellular modifications of human apolipoprotein E. , 1986, The Journal of biological chemistry.

[38]  J. Breslow,et al.  Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. , 1984, The Journal of biological chemistry.

[39]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[40]  R. Mahley,et al.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.